Abstract This randomized controlled pilot trial examined the feasibility, acceptability, and preliminary efficacy of an adapted interpersonal psychotherapy (IPT) for major depressive disorder (MDD) following perinatal loss (miscarriage, stillbirth, or early neonatal death). Fifty women who experienced a perinatal loss within the past 18 months, whose current depressive episode onset occurred during or after the loss, were randomized to the group IPT adapted for perinatal loss (the Group IPT for Major Depression Following Perinatal Loss manual developed for this study is available at no cost by contacting either of the first two authors) or to the group Coping with Depression (CWD), a cognitive behavioral treatment which did not focus on perinatal loss nor social support. Assessments occurred at baseline, treatment weeks 4 and 8, post-treatment, and 3 and 6 months after the end of treatment. IPT was feasible and acceptable in this population. Although some participants were initially hesitant to discuss their losses in a group (as occurred in IPT but not CWD), end of treatment satisfaction scores were significantly (p = 0.001) higher in IPT than in CWD. Confidence intervals around between-groups effect sizes favored IPT for reductions in depressive symptoms during treatment as well as for improvement in mode-specific targets (social support, grief symptoms) and recovery from a post-traumatic stress disorder over followup. This group IPT treatment adapted for MDD after perinatal loss is feasible, acceptable, and possibly efficacious. Perinatal loss increases women's risk for major depressive disorder (MDD; see Klier et al. 2002 for a review). For example, the most rigorous case-controlled study to date (Neugebauer et al. 1997 ) assessed 229 women who had experienced a perinatal loss (before 28 weeks of gestation) and 230 matched community controls. This study found that 11 % of women with perinatal loss experienced a major depressive episode in the 6 months following the loss, compared to only 4 % of community women. Among women with perinatal loss, 72 % of cases of MDD began within the first month after the loss; only 20 % of community cases started during the comparable period. Among women with a history of
Perinatal loss includes early (before 20 weeks; miscarriage) and late (after 20 weeks; stillbirth) fetal death and the death of a live-born neonate in the first 28 days after birth (neonatal death; Armstrong 2002) . For many women, perinatal loss constitutes a traumatic event representing the death of a future child, disruption of reproductive plans, and doubts about procreative competence (Neugebauer et al. 1997) . Despite medical advances, miscarriages occur in 10-15 % of recognized pregnancies (Petrozza 2006) , stillbirths in 1 of 160 live births (CDC 2007) , and neonatal death in an additional 1 of 168 live births (CDC 2015) . About 650,000 women in the USA experience a perinatal loss each year (American Pregnancy 2008) .
Perinatal loss increases women's risk for major depressive disorder (MDD; see Klier et al. 2002 for a review). For example, the most rigorous case-controlled study to date (Neugebauer et al. 1997 ) assessed 229 women who had experienced a perinatal loss (before 28 weeks of gestation) and 230 matched community controls. This study found that 11 % of women with perinatal loss experienced a major depressive episode in the 6 months following the loss, compared to only 4 % of community women. Among women with perinatal loss, 72 % of cases of MDD began within the first month after the loss; only 20 % of community cases started during the comparable period. Among women with a history of MDD, 54 % experienced a recurrence of MDD following the loss. Studies of depression following stillbirth or early neonatal death (vs. miscarriage) have also documented increased depressive symptoms following the loss (Carrera et al. 1998; Clarke and Williams 1979; Klier et al. 2002) . One study (Boyle et al. 1996) found that mothers who experienced a stillbirth or early neonatal death had higher rates of psychological distress (including depressive symptoms) for at least 30 months after their loss than did mothers of living infants. Another research has concluded that Bpregnancy loss is…a stressful life event that can give rise to a marked deterioration in a woman's mental health^ (Janssen et al. 1996, p. 226 ; see also Cordle and Prettyman 1994) .
Despite a high prevalence of MDD and associated impairment among women who have experienced perinatal loss, no previous randomized studies have evaluated the efficacy of any treatment (psychological or pharmacological) for MDD following perinatal loss. Only one study selected women based on elevated depressive symptoms: Neugebauer et al. (2006) compared telephone interpersonal counseling (IPC), a short, highly scripted version of interpersonal psychotherapy (IPT), to community treatment as usual among 19 women who had recently miscarried. Results favored IPC for a decline in depressive symptoms, but women in the IPC arm still had elevated depressive symptoms at the end of treatment. Although indicating promise for IPT-based interventions for depressive symptoms following miscarriage, this study lacked follow-up data and excluded participants who met full MDD criteria. A few other randomized studies (Kersting et al. 2011 (Kersting et al. , 2013 Swanson 1999; Swanson et al. 2009 ) have found brief, three-to five-session counseling interventions to reduce distress, including depressive symptoms, among general (rather than clinical) populations of women with perinatal loss. However, none of these studies enrolled samples selected for MDD or elevated depressive symptoms. In fact, the studies of Kersting et al. excluded individuals with likely MDD or who had suicide ideation. Research on effective treatments for perinatal loss-related clinical disorders, especially MDD (which may include suicide ideation), is needed.
The current study evaluates the feasibility, acceptability, and preliminary efficacy of a version of IPT adapted to the needs of women experiencing MDD after a perinatal loss. IPT is a frontline treatment for MDD in general (Hollon and Shelton 2001 ; National Collaborating Centre for Mental Heath 2010) and perinatal (Clark et al. 2003; Koszycki et al. 2012; O'Hara et al. 2000; Pearlstein et al. 2006; Spinelli and Endicott 2003) populations. IPT works to increase social support and to address interpersonal challenges. Many challenges faced by women experiencing MDD after a perinatal loss are interpersonal. For example, because there are few social norms about how to grieve the death of a new infant or a pregnancy loss (Stirtzinger et al. 1999 ), women may not know how to react or how to ask others to react. Others' avoidance of or discomfort in responding to such an unexpected and sad event may increase women's sense of isolation (Nikcevic 2003; Stirtzinger et al. 1999) . A lack of social support has been associated with greater distress and impairment following perinatal loss (Beutel et al. 1995; Biondi and Picardi 1996; Swanson 2003a) , and positive social support has been found to be associated with better adjustment to perinatal loss (Abboud and Liamputtong 2005; Murray and Terry 1999; Zeanah and Harmon 1995) . IPT can help women identify and request an appropriate support.
Perinatal loss can particularly strain couple relationships, increasing emotional and sexual distance (Schaap et al. 1997; Swanson 2003b) , especially if partners deal with the loss differently (Beutel et al. 1996 ). Women's perceptions of marital difficulties are associated with depression or distress up to a year after the miscarriage (Beutel et al. 1996; Forrest et al. 1982; Stirtzinger et al. 1999; Swanson 2003b) . Therefore, addressing the couple relationship as part of IPT's interpersonal focus may be especially important for women experiencing MDD after a perinatal loss. Despite the importance of couple functioning issues following perinatal loss, none of the previous intervention studies have reported effects of interventions on couple distress or other interpersonal variables.
This pilot study compares a version of group IPT adapted to treat MDD and associated social and interpersonal challenges following perinatal loss to an unadapted standard MDD treatment (Coping with Depression (CWD); Lewinsohn et al. 1984) . The study examines the feasibility and acceptability of the adapted IPT intervention and explores the preliminary evidence for the following hypotheses:
1. Perinatal loss-specific IPT will be more acceptable to women who experience MDD following perinatal loss than will CWD. 2. Perinatal loss-specific IPT will result in (a) reduced time to recovery from MDD and (b) reduced depressive symptoms relative to CWD. 3. Perinatal loss-specific IPT will result in (a) increased social support and social role functioning, (b) reduced couple distress, and (c) reduced grief relative to CWD.
Methods

Treatments and treatment integrity
Both treatments consisted of a pre-group individual session, 12 group sessions, and a 1-month individual booster session (a total of 14 sessions). Groups were slow-open, with group members able to enter the groups every 4 weeks.
IPT
IPT identifies a difficult life event or current interpersonal problem and addresses it by helping the individual to improve communication, to change relationship expectations, and/or to build or better utilize her extended social support network. IPT uses education, therapeutic exploration, communication, and interpersonal incident analysis, and work on building social support to solve the difficulty that triggered the onset of the depressive episode (Weissman et al. 2000) . All three areas in which treatment goals can be set (grief, role transition, and interpersonal disputes) can be adapted to address perinatal loss. A specialized treatment manual (Group IPT for Major Depression Following Perinatal Loss) was developed for this study. It is available at no cost by contacting either of the first two authors.
Adaptations In IPT, a major depressive episode triggered by grief (i.e., bereavement) is typically treated by facilitating the mourning process and by helping patients re-establish interests and relationships that can sustain them (Weissman et al. 2000) . One unique feature of perinatal loss is that women often experience it as a real loss, but it is not always acknowledged by the culture around them (Gilbert and Smart 1992) . As a result, women experiencing perinatal loss need to learn not only how to deal with their own reactions to the loss but also to the reactions of other people. Furthermore, losses such as miscarriage, stillbirth, and early neonatal death involve a Bunique kind of mourning based on unfulfilled expectations and a loss of the normal order of the life cycle^ (Stirtzinger et al. 1999, p. 237) . As a result, the death of an infant or the end of a pregnancy often raises questions about fault, including what happened to the pregnancy, and questions about meaning, including what this unexpected event means to the woman, for her relationship with her partner, about her future, and about whether or not events are predictable or fair (Gilbert and Smart 1992) . Finally, some women feel guilty or feel like they are losing their connection to the baby as they begin to reengage in other activities and think less about the loss. In this study, the IPT goal of facilitating the mourning process and reestablishing social contacts was adapted to help women to (1) cope with others' reactions to the loss, including questions about the baby from acquaintances and cultural attitudes which minimize or ignore the impact of perinatal loss; (2) address issues of fault and meaning; and (3) find ways to maintain a sense of connection to their lost pregnancy or child and still re-engage in meaningful activities and social contacts. Women who experience perinatal loss may also be undergoing repeated role transitions or life changes. For many women, perinatal loss constitutes an unanticipated event representing the death of a future child and disruption of reproductive plans. As a result, it may affect decisions about family, work, and housing plans. Women may be faced with a number of unexpected practical issues such as when and how to return to work and what to do with the baby's room or other baby gifts that had already been received. Reengaging in work and social roles can be challenging for women after a perinatal loss, because women often repeatedly have to explain what happened to the pregnancy or to the infant. Perinatal loss may also affect women's role identification because it may engender doubts about procreative competence (Neugebauer et al. 1997) . Medical complications resulting from the loss may also interfere with a woman's role functioning and require her partner or those around her to temporarily assume other roles (such as care for other children). In standard IPT, role transition issues are addressed by helping patients express guilt, anger, and loss at the change in roles and then helping them acquire the skills, attachments, and supports needed to function in the new circumstances. Our adapted role transition focus addressed women's concerns that they did not adequately perform their role as mothers and to help them make the unexpected transitions to their new roles.
Finally, women who experience a perinatal loss may also be experiencing differing expectations in important relationships or interpersonal conflicts. A stressful event such as a perinatal loss can lead to differences between a woman and her partner or other family members about how to cope with the event or may exacerbate existing tensions. She may also feel estranged from her female peers who have had live births. IPT typically works to ameliorate these difficulties by helping women to identify and express their interpersonal expectations and to negotiate differing expectations effectively with others. In this study, IPT was adapted to help women identify and request the support they need from others following a perinatal loss in the absence of social norms about how to do so. Women were invited to bring their partner or another support person to 3 of the 12 group intervention sessions. These sessions helped couples clarify their needs and expectations of each other (including permission to grieve differently) and reduce conflicts over how to grieve (including discussing different reactions to the loss, different rates of grieving, what they each believe is appropriate public and private grief, and the meaning or intentions of each other's behavior).
Structure Group sessions were semi-structured. Each woman had the opportunity to participate in groups covering the four topics (the emotions of grief, understanding what happened, grieving with others, and holding the memory and moving forward; see Table 1 ) three times: once to begin work on each issue, once to assess progress and problem-solve any difficulties that arise, and then a final time to address any remaining issues and solidify gains. We have found that entering of new women into the groups every 4 weeks allows remaining women to see their own progress and encourages new women -begins to explore who she has talked to about the loss and how she talks to them about her needs -identifies whom she will invite to Session 3 -role-plays how she will communicate this invitation
The therapist -helps each woman unpack and examine whether there was anything she could have done to change the outcome, with help from the group -provides information about what does and does not contribute to perinatal loss -helps women identify additional questions they may have for their ob-gyn providers -helps each woman explore how she makes sense of her loss Session 3
Grieving with others
The therapist actively leads the group with psychoeducation -to understand depression causes and symptoms -to understand grieving processes and styles -to discuss ways to manage grieving differences -to understand how the grief groups help the women recover -to understand how partner and family support help the women recover Then, the therapist guides each partner pair to by illustrating how the grief process and healing develop over time. For example, the emotions and perspective associated with telling one's loss story and feeling the associated feelings (see Table 1 ) changed over women's time in the group (they tended to be less raw and overwhelming and to involve a greater perspective over time).
CWD
The CWD course is a highly structured, manualized (Lewinsohn et al. 1984) , psychoeducational group treatment for MDD. We chose CWD as a comparison condition over other standard depression treatments because it is the group treatment with the most empirical support for treating MDD (Cuijpers 1998; Johnson 2009 ) and because it is distinct from IPT. Theoretically, the CWD course is based on social learning theory which posits that depression is associated with a decrease in pleasant and an increase in unpleasant personenvironment interactions. The course content is cognitive behavioral in nature and is designed to train skills that can be used in the alleviation of depression. CWD sessions covered the following: an introduction to the social learning rationale of depression, learning to relax, relaxation in everyday situations, pleasant activities and depression, formulating a pleasant activity plan, two approaches to constructive thinking, formulating a plan for constructive thinking, and maintaining gains. To avoid overlap with IPT, we removed the two CWD sessions on social skills and expanded the other contents to fill these sessions. CWD focused on skills for reducing depression in general and did not have perinatal loss-specific components. We also instructed CWD therapists to steer conversations away from the perinatal loss and to focus on planning for pleasant activities primarily on solitary, rather than interpersonal, activities. Therefore, our CWD control did not offer the primarily theorized mechanisms of the adapted IPT: work on interpersonal relationships, grief, social support, lossrelated interpersonal challenges, loss-related social support, couple adaptation to the loss, and grief-specific coping. As a result, we chose secondary outcomes (social support and social functioning, couple distress, and grief) that assessed hypothesized differences between treatments.
Therapists IPT therapists included a psychiatric nurse practitioner with expertise in grief and IPT (ABP) and two clinical psychology post-doctoral fellows. CWD therapists included two clinical psychology post-doctoral fellows with CWD expertise and a psychiatry resident. Sessions were audiotaped. Supervision of IPT was provided by JJ and supervision of CWD was provided by CZ. Weekly supervision consisted of audiotaped review and case discussion.
Treatment integrity
Treatment integrity measures were adapted from existing measures for IPT and CWD, with additional items designed to assess theorized differences between treatment conditions (e.g., addressing loss-related interpersonal challenges, lossrelated social support, couple's adaption to the loss, and grief-specific coping). A trained post-doctoral clinical psychology fellow conducted adherence and competence ratings on 14 % of the sessions. The rater also assessed the percent of the time spent on discussing the perinatal loss and discussing loss-related communication strategies (intended differences between conditions) in rated group sessions.
Participants
We recruited women (n = 50) between 18 and 50 years old who (1) had experienced a perinatal loss (including early and late fetal deaths, the death of a live-born neonate within the first 28 days, and termination due to medical indications) in the last 2 weeks to 18 months and (2) currently met all criteria but criterion E (bereavement exclusion criterion) for DSM-IV major depressive disorder as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). To enroll those whose current depressive episode occurred during or subsequent to a perinatal loss, we excluded women whose (1) onset of current major depressive episode occurred prior to news of difficulties with the pregnancy or health risk to the infant (women with prior depressive episodes were included). Other exclusion criteria included: (2) meeting SCID-I criteria for lifetime schizophrenia, schizoaffective, or bipolar I disorder (or, if bipolar II, had hypomania episodes in the last year); (3) current SCID-I drug or alcohol dependence; (4) current SCID-I anorexia/bulimia; (5) severe SCID-II borderline personality disorder; and (6) any IPT or cognitive behavioral treatment in the previous 12 weeks. For women with suicide ideation (n = 14; often a desire to die as a way to join their deceased babies), a licensed clinician evaluated them to ensure that they were stable enough for outpatient care. Women with moderate to severe thyroid difficulties or anemia (determined by appropriate lab tests) were referred for care for these problems before being enrolled in the study. If a possible participant had recently begun psychotherapy or antidepressant medications, the study waited until she was stable on the dose of the other treatments for at least 8 weeks and then verified that she still met the criteria for the current MDD before enrolling her. Because the time following a perinatal loss is sensitive, the study did not approach any women in person for recruitment. Instead, we advertised through pamphlets in clinics and hospitals, a study website, and advertisements on local buses and on the Internet. We also recruited through providers including those in the women's hospital emergency rooms, social work, psychiatry, as well as infertility clinics, primary care, ob-gyn clinics, and loss support groups. After women volunteered for the study, informed consent procedures were conducted before the baseline assessment. Participants were compensated with a $30 gift card for each assessment (a total of six assessments). The study followed ethical guidelines under approval from the institutional review board of both Brown University and Women and Infants Hospital. It was registered at ClinicalTrials.gov under Protocol no. NCT01867749.
Randomization occurred in a 1:1 ratio and was stratified by type of loss (miscarriage, stillbirth, early neonatal death) and whether or not a participant was receiving other mental health (pharmacotherapy or psychotherapy) treatment. The dose of mental health treatment (pharmacotherapy or psychotherapy) was required to have been stable for at least 8 weeks. The random sequence was generated by an individual not affiliated with the study, with group assignment placed in sequentially numbered opaque envelopes that were sealed until the principal investigator verified that each individual was eligible for the study.
Assessments
Study assessments were conducted by trained research assistants (RAs), one of whom was blinded and one of whom was not, and took place between June 2011 and June 2014. Assessments took place at baseline, treatment weeks 4 and 8, immediately following treatment, and 3 and 6 months after the end of treatment. Participants had up to 20 weeks after randomization to complete the 12 group and 2 individual sessions. Therefore, the Btreatment week 4^assessment actually took place after approximately 4 group sessions should have taken place, which was an average of 7 (range 5-11) calendar weeks after baseline, the Btreatment week 8^assessment actually took place an average of 11 (range 9-16) calendar weeks after baseline, the post-group assessment took place an average of 18 (range 11-25) calendar weeks after baseline, and follow-ups an average of 31 (range 25-37) and 45 (range 38-53) weeks after baseline, with no differences between conditions and no relation to depression outcomes. Assessments included structured interviews and self-report measures and took place at our research offices or at women's homes. The Social Adjustment Scale, Inventory of Complicated Grief, and the Dyadic Adjustment Scale were only given at baseline, immediately following treatment, and at the two follow-up assessments. Other measures were given at all time points. Data were double entered with discrepancy resolution.
Feasibility and acceptability
We assessed the feasibility and acceptability of IPT for MDD after perinatal loss and CWD as a control condition by examining rates of treatment attendance, rates of partner or significant other attendance (for designated IPT sessions), and rates of treatment dropout (defined as attending 4 or fewer of the 14 possible intervention sessions). We also examined reasons for termination for consistent patterns. Overall treatment satisfaction was measured with the Client Satisfaction Questionnaire-Revised (CSQ-8-R; Larsen et al. 1979) . We gathered information on the perceived helpfulness of each treatment component using versions of the End of Treatment Questionnaire (Najavits et al. 1998) . We also collected qualitative data on the acceptability of both the adapted IPT-G and the standard CWD using structured individual exit interviews, which asked about the most and least helpful parts of the treatments, the most and least helpful things done by therapists, critical events, responses to the structure of the treatment (i.e., group, allowing new women every 4 weeks), and helpfulness of treatment components.
Time to MDD recovery
The Longitudinal Interval Follow-up Examination (LIFE; Keller et al. 1987 ) interview was used to assess the timing of MDD remission. The LIFE uses psychiatric status ratings (PSRs) to provide weekly ratings of the severity of each DSM-IV MDD symptom on a scale of 1 (asymptomatic) to 6 (incapacitated); therefore, participants can be classified as in episode or out of episode each week. Recovery is defined as eight consecutive weeks of a PSR 1-2 (Keller 2003) ; time to recovery is defined as the number of weeks between baseline and the beginning of the 8+-week series of PSR 1-2. We also tracked post-traumatic stress disorder (PTSD) and non-study treatment received (medications or psychotherapy) using the same method.
Depressive symptoms
Depressive symptoms were assessed using two measures: the 17-item interviewer administered the modified Hamilton Rating Scale for Depression (HRSD; Hamilton 1980) and the self-report Beck Depression Inventory-II (BDI-II; Beck et al. 1996) .
Social and interpersonal variables
We used the 12-item Multidimensional Scale for Perceived Social Support (MSPSS; Dahlem et al. 1991) to assess overall perceived social support. The Social Adjustment Scale (SAS; Weissman and Paykel 1974) was used to assess social role impairment, specifically difficulties in the ability to do work as well as functioning in social and friendship relationships, partner relationships, and parenting and other family relationships. We used the total score (sum of all individual items, excluding the four global rating items at the end); higher scores reflect worse functioning, so this scale is labeled Bsocial role impairment^. We used the Dyadic Adjustment Scale (DAS; Antill and Cotton 1982) to measure couple distress among the 48 (of 50) participants who considered themselves to have intimate partners.
Grief
Grief symptoms were measured using the Perinatal Bereavement Grief Scale (PBGS; Ritsher and Neugebauer 2002) , which measures grief distinct from depressive symptoms (Klier et al. 2002) . Complicated grief is distinct from both typical grief and depression and is characterized by long-standing, chronic disbelief and anger/ bitterness over the death, and intense yearning for and preoccupation with the deceased (Shear et al. 2005) . Symptoms of complicated grief were measured using the Inventory of Complicated Grief (ICG; Prigerson et al. 1995) . A few items on the ICG were slightly reworded to refer to perinatal loss.
Data analysis
The main purpose of this pilot study was to adapt IPT to treat MDD following perinatal loss and to collect feasibility and acceptability data on this adapted intervention. Therefore, this was not a fully powered study. With data from the 50 participants in intent-to-treat analyses and some boost in power provided by repeated measures analysis (Faes et al. 2009 ), we would only have a statistical power adequate (0.80) to detect moderate to large effects (d > 0.50) with an alpha value of 0.05. With an evidence-based, active control condition (CWD), smaller effect sizes (d ∼0.3-0.4) are more likely, reducing power to 39-61 %. Per Kraemer et al. (2006) , between-conditions comparisons in pilot studies like this should be considered exploratory and report 95 % confidence intervals around observed effect sizes for all betweenconditions comparisons. Therefore, rather than providing definitive tests of treatment effects, analyses examined the direction of effects and the range of effect sizes for differences between conditions. Analyses were intent-to-treat; strategies used (hierarchical linear modeling (HLM) for repeated measures and Cox regression) can accommodate missing data. There were no interim analyses or trial stopping rules.
Most feasibility and acceptability measures were evaluated descriptively. However, we examined preliminary evidence to support the hypothesis (hypothesis 1) that the adapted IPT treatment was more acceptable than the CWD treatment using t tests to compare CSQ treatment satisfaction scores, number of sessions attended, and dropout (attending 4 or fewer of the 14 possible sessions) rates between conditions.
We calculated the effect size and confidence intervals for time to recovery from depressive episode (hypothesis 2a).
Exploratory tests for differences between conditions used Cox regression, with condition as the predictor and initial HRSD score as the covariate. We also explored time to PTSD recovery among the participants meeting criteria for PTSD at the beginning of the study. We also calculated between-conditions effect sizes and confidence intervals for reduction in depressive symptoms using HRSD and BDI-II scores (hypothesis 2b). Separate exploratory tests for differences between conditions used HLM with baseline scores as covariates. We did not compare the slopes of change in this small study, but instead specified the model to compare the mean difference between conditions across all post-intake time points.
Per hypotheses 3a, 3b, and 3c, we also estimated the effect sizes and 95 % confidence intervals for the adapted IPT treatment relative to CWD for social support and social role impairment (MSPSS and SAS total scores), couple distress (DAS scores), and grief (PBGS and ICG scores). Separate exploratory tests for differences between conditions used HLM with baseline scores as covariates. Differences in scores within conditions from baseline to 6-month follow-up used paired-sample t tests.
Dose-response analyses added the total number of study treatment sessions attended as an additional predictor of HRSD score (using HLM) and incidence of MDD recovery (using Cox regression) over post-intake assessment points. We also explored whether bringing a partner to at least one treatment session was an additional predictor of post-intake DAS scores (using HLM). Finally, we calculated how many participants engaged in new non-study treatment during the active treatment and follow-up phases and whether engaging in new nonstudy treatment was a predictor of post-intake HRSD scores or MDD remission.
Results
Sample
About two thirds of the sample was non-Hispanic White. Women were, on average, around 30 years old and living with a romantic partner. About half experienced miscarriage, and 40 % experienced stillbirth (or late fetal death, 20-40 weeks of gestation). Women enrolled in the study had a mean of 10 weeks (range 2-49 weeks) after their loss. Nearly two thirds had previous depressive episodes, and the participants were, on average, severely depressed at baseline (see Table 2 for more details). The most frequent comorbidity with MDD in our sample was symptoms meeting criteria for posttraumatic stress disorder (PTSD) except duration (a few women were assessed less than 1 month after their loss). A majority of women in our study (n = 27; 54 %) had these high levels of PTSD symptoms (19 related to the recent perinatal loss, 3 from another trauma only, and 5 from both traumas). Other common comorbidities included generalized anxiety disorder (n = 6; 12 %) and panic disorder (with or without agoraphobia; n = 6; 12 %). Because complicated grief is diagnosed by having a score of at least 30 on the Inventory of Complicated Grief at least 12 months after a loss (K. Shear, personal communication, January 10, 2012) and because the time since the loss at intake ranged from 1.4 to 49.1 weeks in our sample, no participants met criteria for complicated grief at intake.
The CONSORT table in Fig. 1 shows the flow of participants through the study. Follow-up rates were 66 % for week 4, 76 % for week 8, 72 % for the post-treatment assessment, 68 % for the 3-month follow-up, and 78 % for the 6-month followup, with 90 % of participants providing at least some follow-up data. Overall, the participants completed a mean of 3.6 f/u assessments (of 5) per person; the mean number of follow-up assessments completed did not differ by treatment condition (t = 0.48, degree of freedom (df) = 48, p = 0.63). Data on attendance at study treatment are available for all 50 participants. (14) 69 (13) 64 ( (11) 96 (17) 94 (14) MDE major depressive episode a Participants with lower scores are better off b Participants with higher scores are better off
Feasibility and acceptability
Attendance
Of the 14 possible group and individual sessions, CWD participants (n = 25) attended a mean of 7.3 (SD = 5.5) sessions and IPT participants (n = 25) attended a mean of 9.3 (SD = 5.2) sessions (d = 0.37, 95 % CI = −0.19 to 0.94, p = 0.19). Nine of the 25 IPT participants (36 %) had a partner who participated in at least one (M = 1.9) treatment session. Reasons given by partners not coming to treatment sessions included not having a partner, partner's work schedule, or partner being unwilling to come. Among those whose partners did attend at least one session, these sessions were perceived to be, on average, very helpful. Seven of 25 (28 %) IPT participants and 11 of 25 (44 %) CWD participants were considered to have dropped out of study treatment (attended 4 or fewer of 14 study treatment sessions; χ 2 = 1.39, df = 1, p = 0.24). Reasons for dropout given by IPT participants included Bdidn't want to be in a group with grieving women when she was 8 months pregnant,^Blost contact,^Bscheduling conflict with group time,^a nd Bprefers medication.^Reasons for dropout given by CWD participants included Bdidn't want to bring up the feelings again,^Bwanted to focus on her loss^(n = 4), Bdidn't think she was depressed,^and Blost contact^(n = 5).
Satisfaction with study treatments (hypothesis 1)
CSQ treatment satisfaction scores were higher in the IPT condition than in the CWD condition (t = 3.54, df = 33, p = 0.001, d = 1.03, 95 % CI[d] = 0.44 to 1.63). On the End of Treatment Questionnaire scale items from B−3 = very harmful^to B3 = very helpful,^IPT received significantly higher scores than did CWD for Bintervention helped with your depression( p = 0.03), Bintervention helped you adjust to life after perinatal loss^(p < 0.001), and the Bhelpfulness of the intervention, overall^(p = 0.01). The mean helpfulness rating of specific IPT treatment components (telling the story of the loss, discussion of what caused the loss, what the loss means, bringing a support person to group, information about how people grief differently, work on how to communicate with others about the loss, how to remember the baby, and how to re-engage in 120 were assessed for eligibility 70 were excluded 14 outside RI and Eastern MA 23 loss out of time frame (> 18 months) 4 no loss 11 no MDD 4 current depressive episode began before loss 8 bipolar, borderline, or substance dependent 2 began other treatment within past 8 weeks 1 each: age out of range, did not speak English, SI/HI warranting hospitalization, unable to give informed consent 3 were lost to follow-up 25 were assigned to IPT 25 were assigned to CWD 50 were randomized 168 women were referred (84) or self-referred (84) 48 did not complete the baseline assessment 17 declined to participate 31 no-showed or lost contact 7 dropped out of treatment (attended 4 or fewer of 14 sessions) 18 completers attended a mean of 12 sessions 11 dropped out of treatment (attended 4 or fewer of 14 sessions) 14 completers attended a mean of 12 sessions 2 were lost to follow-up 22 were included in intent-to-treat analyses 23 were included in intent-to-treat analyses Fig. 1 Consort diagram other life roles) was 2.34 (SD = 0.43). The mean helpfulness rating of specific CWD treatment components (learning about what causes depression, learning to relax, applying relaxation in everyday situations, planning for pleasant activities, learning constructive thinking, making a plan for construct thinking, planning to hold onto what was learned, and treatment handouts and homework) was 1.98 (SD = 0.96). When asked what they would do if designing their own intervention for women experiencing depression after a perinatal loss, participants in both conditions said that they would provide the same or a very similar treatment to the one they received. When asked open-ended questions in exit interviews about helpful aspects of the treatments, several participants in both conditions mentioned the opportunity to hear about other women's experiences with depression and feeling supported and not judged. In addition, the IPT participants valued the opportunity to express and normalize feelings and CWD participants valued learning relaxation and pleasant activities skills.
Reactions to discussing/not discussing the loss In the exit interviews, many women in the IPT condition described telling the story of their loss as difficult but helpful (Bit helped me process it better^) and all rated it as helpful on the End of Treatment Questionnaire (M = 2.52, SD = 0.60). Although initially concerned about hearing other women's loss stories, most IPT participants also described this as helpful in the exit interviews; however, one woman who had a miscarriage said that she did not like hearing about stillbirths because she Bdidn't want to know that could happen.^In exit interviews with CWD participants, at least two said they would have liked to directly discuss the loss. However, another three described wanting to talk about the loss at first but ultimately deciding it was better not to in the end. Therefore, despite significant differences in treatment satisfaction between conditions, the participants seemed to try to find ways to make the best of whatever treatment they received.
Treatments and treatment integrity
Across rated IPT and CWD tapes, therapists spent 95 % of the session time on model topics/activities (89 % for IPT and 99 % for CWD), 3 % of the time on opposite-model topics/activities (5 % for IPT and 2 % for CWD), and 3 % of the time on topics/ activities from neither model (6 % for IPT and 0 % for CWD; numbers do not add to 100 % due to rounding). In terms of specific expected differences between conditions, 30 % of the time in rated IPT sessions was spent on talking about the perinatal loss (vs. 1 % in CWD, p < 0.001); 14 % of the time in rated IPT sessions was spent on facilitating mourning including guilt, anger, and sadness (vs. 0 % in CWD, p < 0.001); and 51 % of the time in rated IPT sessions was spent on discussing loss-related communication (vs. 0 % in CWD, p < 0.001). Every rated IPT session involved a discussion of how the couple was dealing with the loss, whereas only one rated CWD session did. IPT participants spent more time feeling (45 vs. 6 %, p < 0.001), less time thinking/learning intellectually (28 vs. 56 %, p < 0.001), and about the same amount of time doing (including practicing/planning; 27 vs. 38 %, NS) as CWD participants. All items reflecting work on relationships, communication, social support, interpersonal conflicts, the loss itself, effects of the loss, grief, and exploration of emotions differed significantly (p < 0.01) between conditions.
On a scale from B1 = poor^to B7 = ideal,^the independent rater rated IPT sessions between B4 = moderate^and B7 = ideal^quality in terms of helping group members take concrete steps toward solving interpersonal problems or increasing social support (M = 4.7), helping them experience emotions (M = 3.9), helping group members disclose and feel safe/comfortable (M = 6.6), and overall quality of the session from an IPT perspective (M = 4.9). CWD sessions were rated in the same range for helping group members take concrete steps toward changing thoughts/activities (M = 5.2), delivering assigned lecture materials (M = 5.6), assigning and reviewing homework (M = 6.1), and the overall quality of the session from a CWD perspective (M = 5.5).
Other outcomes
Time to MDD recovery (hypothesis 2a)
Controlling for intake HRSD score, non-significant Cox regression results favored the IPT condition (B = 0.30, SE[B] = 0.41, Wald = 0.52, p = 0.47). The hazard ratio was 1.35 (95 % CI = 0.60-3.02), indicating that the participants in the IPT condition had a 35 % higher incidence of MDD recovery at any given time during the study (95 % CI = 40 % lower to three times as high) than did those in the CWD condition (see Fig. 2 ). Among those who recovered, the median time to recovery was 15 weeks from baseline for IPT participants and 22 weeks from baseline for CWD participants.
Time to PTSD recovery Among the subset of women who met criteria (with the possible exception of time since the trauma) for PTSD at baseline, significant Cox regression results favored IPT (B = 1.73, SE[B] = 0.67, Wald = 6.78, p = 0.009). The hazard ratio was 5.65 (95 % CI = 1.54-20.82), indicating that the participants in the IPT condition had nearly 6 times the incidence of PTSD recovery at any given time during the study (95 % CI = 54 % higher to 20.8 times) as did those in the CWD condition (see Fig. 2 ). Among those who recovered, the median time to recovery was 11 weeks from baseline for IPT participants and 24 weeks from baseline for CWD participants.
Reduction in depressive symptoms (hypothesis 2b)
Depressive symptom (HRSD) scores improved significantly from baseline to 6-month follow-up in both conditions (from 26 to 8 in IPT and from 24 to 7 in CWD; both p < 0.001).
Differences between conditions on HRSD and BDI scores averaged over the entire period (including follow-up) were extremely small to non-existent (see Table 3 ). However, post hoc analyses of HRSD scores across during-treatment (4 weeks, 8 weeks, and post-group) assessments only Fig. 2 Survival plots for time to recovery from major depressive episode (MDE) and posttraumatic stress disorder (PTSD) by condition. Recovery is defined as eight consecutive weeks of being asymptomatic or having one to two symptoms to a very mild degree (i.e., scoring PSR 1-2 on the LIFE). The week shown is the first week of the recovery period (excluding the 6-month follow-up period) estimated a between-conditions effect size of d = 0.36 (95 % CI = −0.04 to 0.75) favoring IPT (see Table 3 ). This finding is consistent with the (non-significant) survival analyses for recovery from MDD, which suggested the possibility for faster MDD recovery in the IPT condition.
Improvements in social support and social functioning, couple's distress, and grief (hypotheses 3a, 3b, and 3c)
Within-subjects comparisons SAS social role impairment scores decreased significantly (p = 0.001), and MSPSS social support scores improved trend-significantly (p = 0.06) from baseline to 6-month follow-up in IPT; neither of these improved in CWD. Grief (PBGS) and complicated grief (ICG) scores improved significantly over time in both IPT and CWD conditions (all ps < 0.001), though this appeared to occur (non-significantly) sooner in the IPT condition. Dyadic adjustment (DAS scores) did not change significantly over time in either condition.
Comparisons between IPT and CWD conditions Analyses of likely effect size ranges for the comparisons between conditions for MSPSS social support and SAS social role impairment scores across all post-intake assessments favored IPT for better outcomes, with d ∼0.27 for each (see Table 3 for ranges). Analyses of likely effect size ranges for PBGS grief symptoms also favored IPT (d = 0.33; see Table 3 ). There was no compelling evidence for a difference between conditions in ICG complicated grief symptoms and no evidence at all for a difference between conditions on DAS dyadic adjustment scores across the post-intake assessments (see Table 3 ). Of the 38 women who provided 6-month follow-up data, only one had symptoms that would meet criteria for complicated grief (ICG score of at least 30); this participant was in the CWD condition.
Dose-response
Accounting for treatment condition and intake HRSD score, the total number of study treatment sessions attended was a significant predictor of MDD recovery (p = 0.001). The hazard ratio was 1.20 (95 % CI = 1.07-1.34), indicating that for each additional treatment session attended, the incidence of MDD recovery at any given time rose by 20 %. Accounting for treatment condition and intake HRSD score, more study treatment sessions attended also significantly predicted lower depressive symptoms across all post-intake assessments (B = −0.59, SE[B] = 0.12, t = −4.96, p < 0.001). There were no interactions between the number of sessions attended and the intervention condition in predicting either MDD recovery or reduced depressive symptoms, meaning that more sessions attended meant better outcomes in both intervention conditions. Accounting for intake DAS score, the IPT participants who had a partner attend at least one treatment session (n = 9) had a trend that is significantly better improvements in dyadic adjustment across all postintake assessments (F = 3.51, df = 1, p = 0.06, d = 0.34, 95 % CI[d] = −0.02 to 2.06) than did participants (IPT and CWD) who did not have at least one session with a partner.
Other treatments
Of the 45 participants on whom follow-up data were available, 22 began new treatment (including another psychotherapy, seeing a provider about psychiatric medications, or starting any psychiatric medication; 9 in the IPT condition and 13 in the CWD condition), despite us asking them not to, during the active treatment phase (p ∼0.2 for the difference between conditions). An additional 8 did so during the 6-month study follow-up period (6 in the IPT group and 2 in the CWD group). Accounting for intake HRSD score, initiating new non-study treatment after intake was not associated with incidence of MDD remission (p = 0.64) or with post-intake HRSD scores (p = 0.11; if anything, those who initiated new treatment had slightly worse HRSD scores). There were no study-related serious adverse events (SAEs).
Discussion
MDD that occurs in the context of perinatal loss is a critical public health problem because of its prevalence and because women who experience MDD in the context of perinatal loss suffer both MDD-and loss-related impairment. Unique social issues faced in the context of perinatal loss warrant a specific, adapted treatment, yet treatments for any disorder in this vulnerable population have not been adequately investigated. In addition, very few treatment studies to date have included women having experienced stillbirth or neonatal death. This randomized controlled pilot study is a first step toward addressing an important research and treatment need by providing and evaluating a treatment addressing the interpersonal and social factors that place women who experience a perinatal loss at risk of continued MDD, morbidity and impairment. This pilot study explored whether an IPT adapted specifically for perinatal loss was more acceptable to patients and better alleviated MDD (and associated social and interpersonal challenges) relative to a generic depression treatment (CWD) with different purported mechanisms of change. Our adapted IPT was feasible and acceptable. As expected, IPT (which directly addressed the perinatal loss, grief, and associated interpersonal challenges in an emotion-focused way) yielded significantly higher CSQ treatment satisfaction scores than did CWD (a cognitive behavioral intervention that addressed depression, but not the loss; hypothesis 1). IPT was also rated as significantly more helpful with depression and with life after perinatal loss compared to CWD. Nonsignificant differences in treatment attendance also favored IPT. Although women varied to some extent at randomization about their desires to tell the story of their loss and hear about others' losses in a group setting, IPT participants said in exit interviews that doing so was Bdifficult but helpful.^Most CWD participants reconciled themselves to not discussing their losses in group. Therefore, although participants seemed to try to find ways to make the best of whatever treatment they received, IPT was more acceptable overall.
Therapist training procedures and treatment manuals which resulted from this development project were also feasible and acceptable, yielding excellent adherence and good competence. The interventions differed in theorized ways: our data demonstrated that IPT sessions had significantly more time spent on talking about the perinatal loss, facilitating mourning, and discussing loss-related communication than did CWD sessions. Relative to CWD sessions, IPT sessions spent more time eliciting feelings and expressing emotions related to the loss and less time thinking/learning intellectually. Thus, the study was successful in creating two theoretically and practically distinct treatments for comparison.
Effect size ranges favored the IPT condition for faster time to MDD recovery, faster time to PTSD recovery, and for larger decreases in depressive symptoms during treatment. However, depressive symptoms of participants in both conditions improved significantly over the study period, with no differences in depressive symptoms between conditions by 6 months after the end of treatment. Study treatment attendance was related to more improvement in depressive symptoms in both conditions. Effect size ranges also favored the IPT condition for improvements in social support (MSPSS scores), social role impairment (SAS scores), and grief symptoms (PBGS scores; see Table 3 ), but not for complicated grief (ICG scores) or for couple functioning (DAS scores). It may be that IPT had no effect on complicated grief or on couple functioning relative to CWD. For example, one CWD participant spontaneously mentioned that her husband liked CWD because it made her Bless grumpy^as her depression improved. However, two other explanations are possible. The first is that, examining change curves over time (not shown), IPT resulted in faster changes, meaning that the largest differences between conditions were found during the active treatment phase rather than the followup period. Unfortunately, complicated grief and dyadic adjustment were not assessed during treatment, but only at baseline and during the follow-up phase. Therefore, we would have missed any differences between conditions in these outcomes during the active treatment phase. The second explanation is that only 9 of the 25 IPT participants had a partner attend at least one treatment session. These participants had a trend that is significantly (p = 0.06) larger improvements in dyadic adjustment across all post-intake assessments than did participants (IPT and CWD) who did not have at least one session with a partner. Given the importance of couple issues to adjustment after perinatal loss, couple functioning should be continuously targeted in future research in this area.
This study examining the feasibility and acceptability of an adapted IPT treatment and exploring its preliminary efficacy relative to CWD for theoretically salient outcomes had several strengths. Strengths include the randomized controlled trial (RCT) study design; an active, well-established, wellspecified control condition; the use of treatment manuals; a good therapist adherence resulting in clear differences between conditions; a well-characterized sample; a thorough assessment of feasibility/acceptability and preliminary efficacy; and a focus on an at-risk, understudied population (i.e., a perinatal loss sample meeting full criteria for MDD, which included women who had experienced stillbirth and neonatal death, not just miscarriage). The primary limitation is the limitation of all pilot randomized trials, which is that a lack of power precludes strong efficacy conclusions. Another potential limitation is that, despite us asking them not to do so, many participants, especially CWD participants, began other MDD treatments (medications or psychotherapies) during the active treatment phase. If anything, this may have provided a potential advantage to the CWD condition.
In sum, this randomized controlled pilot RCT demonstrated the feasibility and acceptability of our adapted IPT for MDD after perinatal loss and its superior acceptability relative to CWD (p < 0.001), and provided some evidence of preliminary efficacy in terms of faster recovery from disorder, reduced in-treatment depressive symptoms, and more improvement in social support, social functioning, and grief symptoms. A full-scale RCT is warranted. From a longer-term perspective, this program of research will result in a specialized, efficacious treatment for a vulnerable and understudied population whose distress has historically been minimized and will therefore have important clinical and public health significance.
